0002001011-24-000048.txt : 20240426 0002001011-24-000048.hdr.sgml : 20240426 20240426183531 ACCESSION NUMBER: 0002001011-24-000048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240424 FILED AS OF DATE: 20240426 DATE AS OF CHANGE: 20240426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOZARICH JOHN W CENTRAL INDEX KEY: 0001223000 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 24885899 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-04-24 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001223000 KOZARICH JOHN W 555 HERITAGE DRIVE SUITE 200 JUPITER FL 33458 1 0 0 0 0 Common Stock 2024-04-24 4 M 0 2893 39.35 A 42523 D Non-Qualified Stock Option (right to buy) 39.35 2024-04-24 4 M 0 2893 0.0 D 2024-06-04 Common Stock 2893 0 D This Option was previously reported as a Grant of 3,312 shares, which vested in full on April 24, 2015, at an exercise price of $67.53 per share, but was adjusted pursuant to the OmniAb Inc. separation from the issuer. By: /s/ Andrew Reardon, Attorney-in-Fact For: John W. Kozarich 2024-04-26